Trainings By Informa Markets

Risk Assessment: A Unique Strategy to Avoid Nitrosamines

Duration - 76 Minutes

About the course

Practical Approaches to risk assessments
  • How to conduct a risk assessment and to identify key factors
  • Applicability to use ICH M7 based cancer risk assessment to the cohort of concern
  • Assessment and communication of risks considering expectations by regulatory authorities

Speaker Profile

Dr. Venkat Manohar

Indian Institute of Chromatography & Mass Spectrometry (IICMS)

Dr. Aloka Srinivasan

Principal - RAAHA LLC.
Former USFDA

Dr. Andrew Teasdale

Senior Principal Scientist Impurity management and External Advocacy

Dr. George Johnson

Swansea University

Dr. Joel Bercu

Senior Director
Gilead Sciences

Website by: Xpoteck